Medicis Misses Zacks Consensus (AGN) (MRX)
Medicis Pharmaceutical Corp.’s ( MRX ) third quarter fiscal 2011 earnings per share (EPS) declined 16.1% from the prior-year quarter to 56 cents. While third quarter 2011 earnings were within management’s guidance range of 48 cents to 67 cents per share, earnings were well below the Zacks Consensus Estimate of 61 cents per share. Higher research and development (R&D) and promotional costs during the quarter pulled the earnings down. […]